About Formycon AG (FYB)
Formycon AG is a Biotechnology company operating in the Healthcare sector.
FYB trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap stock .
Key Statistics
- Current Price
- €18.88
- Market Cap
- N/A
- 52-Week High
- €26.95
- 52-Week Low
- €15.80
- Sector
- Healthcare
- Industry
- Biotechnology
€1,000 Invested in Formycon AG (FYB)
How much would €1,000 invested in FYB be worth today?
What would €1,000 invested in FYB 1 year ago be worth today?
A €1,000 investment in Formycon AG (FYB) in 2025 would be worth €862 as of November 2026, representing a -13.8% total return.
What would €1,000 invested in FYB 3 years ago be worth today?
A €1,000 investment in Formycon AG (FYB) in 2023 would be worth €339 as of November 2026, representing a -66.1% total return.
What would €1,000 invested in FYB 5 years ago be worth today?
A €1,000 investment in Formycon AG (FYB) in 2021 would be worth €370 as of November 2026, representing a -63.0% total return.
What would €1,000 invested in FYB 10 years ago be worth today?
A €1,000 investment in Formycon AG (FYB) in 2016 would be worth €998 as of November 2026, representing a -0.2% total return.
What would €1,000 invested in FYB at IPO be worth today?
A €1,000 investment in Formycon AG (FYB) at IPO would be worth €2,257 as of November 2026, representing a +125.7% total return.
Monthly Returns Heatmap
Over the past 15+ years (189 months), Formycon AG (FYB) has averaged a monthly return of +1.36% with a median return of +0.00%. The stock had 92 positive months (49%) and 94 negative months (50%). The best month in FYB's history was March 2015 with a +63.2% return, while the worst was February 2025 at -50.2%. Historically, December tends to be the strongest month (averaging +7.8%), and August the weakest (-5.1%).
FYB's longest winning streak was 5 consecutive months of gains, while its longest losing streak was 9 consecutive months of losses. The best full year was 2013 with a cumulative return of +109.3%, and the worst was 2012 at -63.6%.
Annual Returns
Over 15 years of trading history, Formycon AG (FYB) has delivered an average annual return of +20.62% with a median return of +11.32%. The compound annual growth rate (CAGR) is +7.53%. The stock posted gains in 9 years (60%) and losses in 6 years (40%).
FYB's best year was 2013 with a +151.98% gain, while the worst was 2012 at -52.97%. The longest streak of consecutive positive years was 5, and the longest losing streak was 4 years. FYB achieved double-digit gains (10%+) in 8 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -26.25% | €25.60 | €18.88 |
| 2025 | -51.79% | €53.10 | €25.60 |
| 2024 | -5.85% | €56.40 | €53.10 |
| 2023 | -34.80% | €86.50 | €56.40 |
| 2022 | +46.61% | €59.00 | €86.50 |
| 2021 | +11.32% | €53.00 | €59.00 |
| 2020 | +66.14% | €31.90 | €53.00 |
| 2019 | +22.69% | €26.00 | €31.90 |
| 2018 | -20.48% | €32.69 | €26.00 |
| 2017 | +36.86% | €23.89 | €32.69 |
| 2016 | +0.53% | €23.76 | €23.89 |
| 2015 | +124.52% | €10.59 | €23.76 |
| 2014 | +40.76% | €7.52 | €10.59 |
| 2013 | +151.98% | €2.98 | €7.52 |
| 2012 | -52.97% | €6.35 | €2.98 |
Frequently Asked Questions: FYB
What sector is FYB in? ▼
FYB operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has FYB performed historically? ▼
Over 15 years of trading history, FYB has posted gains in 9 years (60% of the time). The best year was 2013 with a +152.0% return. Past performance does not guarantee future results.
How can I invest in FYB? ▼
You can invest in FYB through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold FYB.
Last updated: 11/1/2026